Why Many Cancer Drugs Don’t Have To Cost So Much

Image courtesy of ASH Clinical News © The American Society of Hematology
as seen in Forbes (Image courtesy of ASH Clinical News © The American Society of Hematology)

The concept of valuing drugs, at least in part, by how easy it is to reliably produce, distribute and take them, appeals to reason.

Scroll to Top